hi-res version (JPG) 0.99Mb Duncan Learmouth was appointed Senior Vice President, Global Communications in July 2006. He is a member of the Corporate Executive Team, and has responsibility for Media Relations, Investor Relations, Corporate Responsibility, Global Community Partnerships, Internal Communications and Product Communications. Duncan is also a member of the Board of Directors of ViiV Healthcare, the new specialised HIV company established by GSK and Pfizer.
Duncan joined Glaxo Wellcome in 1991 and joined the Investor Relations department in 1997. In November 2001 he was appointed Vice President, Global Investor Relations with responsibility for the Global IR function, reporting to the CFO. In February 2006 he added the Competitive Excellence function to his responsibilities, including the role of secretary to the Corporate Executive Team.
Prior to Investor Relations, Duncan was a Senior Financial Analyst within the Corporate Finance department responsible for the Group's strategic plan. He has also been Financial Controller of Adechsa SA based in Zug, Switzerland and worked in the Financial Investigations and Trading Arrangements departments, both also part of Corporate Finance.
Before moving to Glaxo Wellcome, Duncan was with Deloitte and Touche in London from 1988, qualifying as a Chartered Accountant in 1991. Duncan was educated at Durham University where he gained a degree in Chemistry.
